XDR-TB: Indian perspective

Singh A.

Source: Eur Respir J 2007; 30: 178-179

Journal Issue: July

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Singh A.. XDR-TB: Indian perspective. Eur Respir J 2007; 30: 178-179

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

XDR-TB in South Africa: from clinical management to public-health action Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management Year: 2011
XDR-TB and MDR-TB in Europe: still a challenge Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management Year: 2011
MDR-TB in Eastern Europe: new public health interventions Source: International Congress 2016 – The problem of multidrug-resistant tuberculosis Year: 2016
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
The health economics of treating MDR-TB in the Indian private sector Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016
Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
A study of tuberculosis in an expatriate Nepalese community in South-East London Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Multidrug-resistant tuberculosis in Eastern Europe: still on the increase? Source: Eur Respir J 2012; 39: 1290-1291 Year: 2012
Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective Source: Eur Respir J 2010; 35: 936-938 Year: 2010
National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019
Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
A retrospective analysis of quinolone prescriptions for tuberculosis in two North Birmingham hospitals Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
The global response to rifampicin-resistant tuberculosis: Current situation and recent trends Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement Source: Eur Respir J 2014; 44: 23-63 Year: 2014
Trend in TB control in Republic of Moldova: High MDRTB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Implementing a model for MDR-TB control in a post-Soviet state: experience from Moldova Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management Year: 2013